Publication | Closed Access

Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial

ThrombosisVascular DiseaseCardiovascular DiseasePharmacologyCardiovascular PharmacologyBlinded-endpoints TrialPreventive CardiologyVascular Ehlers-danlos SyndromeMedicineAtherosclerosisCardiovascular Events